Detection of CD4+ T-lymphocytes from hemodialyzed patients by surface plasmon resonance
A surface plasmon resonance (SPR) method was presented to discriminate hemodialyzed T-lymphocytes from the normal based on antibody--cell recognition. By dynamic reaction with fixed anti-human CD4 antibody, SPR could offer significant signals to distinguish hemodialyzed patients from the healthy con...
Saved in:
Published in | Chinese chemical letters Vol. 23; no. 12; pp. 1393 - 1395 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
01.12.2012
School of Chemistry and Chemical Engineering, Shanxi Datong University, Datong 037009, China%East Section of Dongzhimen Hospital Affiliated, Beijing 101100, China%Community Health Service of Beijing Sport University, Beijing 100190, China%Key Laboratory of Analytical Chemistry for Living Biosystems, ICCAS, Beijing 100190, China |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A surface plasmon resonance (SPR) method was presented to discriminate hemodialyzed T-lymphocytes from the normal based on antibody--cell recognition. By dynamic reaction with fixed anti-human CD4 antibody, SPR could offer significant signals to distinguish hemodialyzed patients from the healthy controls within 200 s after the cell injection in respect of either rising speed or maximum binding capacity (p 〈 0.01). The ratio method is also used to exclude the non-specific adsorption. The percentage of hemodialyzed patients' CD4+ T ceils against the healthy control is 69 ± 18%. The most attractive of the present method is its ability to detect the intact and label-free lymphocytes, and further to detect the subpopulations, or proteins secreted by the desired lymphocytes subset. |
---|---|
Bibliography: | Hemodialyzed patients; CD4+ T-lymphocytes; Antibody-antigen interactions; SPR 11-2710/O6 A surface plasmon resonance (SPR) method was presented to discriminate hemodialyzed T-lymphocytes from the normal based on antibody--cell recognition. By dynamic reaction with fixed anti-human CD4 antibody, SPR could offer significant signals to distinguish hemodialyzed patients from the healthy controls within 200 s after the cell injection in respect of either rising speed or maximum binding capacity (p 〈 0.01). The ratio method is also used to exclude the non-specific adsorption. The percentage of hemodialyzed patients' CD4+ T ceils against the healthy control is 69 ± 18%. The most attractive of the present method is its ability to detect the intact and label-free lymphocytes, and further to detect the subpopulations, or proteins secreted by the desired lymphocytes subset. |
ISSN: | 1001-8417 1878-5964 |
DOI: | 10.1016/j.cclet.2012.10.017 |